$BRRN Balance Sheet | Understand Stock

$BRRN

$0.36 +$0.23 (174.42%) Close

$BRRN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q1 FY2024 As of Mar 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2020 As of Oct 31, 2020	Q2 FY2020 As of Jul 31, 2020	Q1 FY2020 As of Apr 30, 2020	Q4 FY2012 As of Jan 31, 2013	Q3 FY2012 As of Oct 31, 2012	Q1 FY2012 As of Apr 30, 2012	Q4 FY2011 As of Jan 31, 2012
Cash
Prepaid assets
Deferred financing costs
Prepaid expenses
Accounts receivable other
Current assets
Property and equipment, net
Security deposit
Total Assets
Checks written in excess of cash
Notes and convertible notes net of discount
Notes, convertible notes, lines of credit payable to former related parties, net of discount
Convertible notes, net of discount
Accounts payable and accrued expenses
Accounts payable and accrued expenses to former related parties
Notes payable
Notes payable -related party
Derivative liability
Accounts payable
Related party loans
Related Party
Total related party loans

Notes payable, related parties
Convertible notes, net of discount
Derivative Liability
Current liabilities
Total liabilities
Common stock, par value $0.001, 2,500,000,000 shares authorized and 2,161,592,112 (January) and 1,693,481,423 (July) outstanding
Stockholders’ Deficit
Preferred stock, par value $0.001, 10,000,000 shares authorized, 10,000,000 issued and outstanding as of June 30, 2026 and December 31, 2025 respectively
Common stock, par value $0.001, 500,000,000 shares authorized, 450,000,000 and 419,984,423 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock to be issued
Common stock issuable
Additional paid in capital
Accumulated deficit
Total Stockholders' Deficit
Total Stockholders’ (Deficit)
Total Liabilities and Stockholders’ Deficit

Comments